ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010